Lv7
3210 积分 2023-11-20 加入
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
11天前
已完结
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
19天前
已完结
Exosite-mediated targeting of GSDMB by dimeric granzyme A in lymphocyte pyroptotic killing
20天前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
28天前
已完结
Inflame and restrain — the paradoxical roles of IL-12 and IL-23 in immunity
1个月前
已完结
PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming
1个月前
已完结
Computational Mapping of Conformational Dynamics and Interaction Hotspots of Human VISTA with pH-Selective Antibodies
1个月前
已完结
Interleukin-23 biology linking mucosal immunity to autoimmune diseases and cancer
1个月前
已完结
Pathogenic IgE-fated memory B cell responses retain functional plasticity
1个月前
已完结
Cancer cell death: Cell-autonomous and immunogenic dimensions
1个月前
已完结
皖公网安备34019202002308
